Company Long-Term Loans and Borrowings: MiMedx Group (MDXG)

Public company logo of MiMedx Group (MDXG)

The price history on the MiMedx Group, Inc. (MDXG) chart is based on the sale of placental biomaterials to surgeons and ophthalmologists, with the current indicator standing at 0.01. The business remains vulnerable due to tissue supply complexities and the uncertainty of FDA rulings. Meanwhile, the company relies on stable, macro-independent demand, transforming its assets into a safe haven during market downturns.

MDXG MiMedx Group, Inc. Company Long-Term Debts (07/04/2022 - 10/29/2026)

Summary analytical data breakdowns for MiMedx Group (MDXG)

- market price and analyst price targets:
Stock Price mimedx.com|MDXG - Price Target Chart
- company stock exchange capitalization indicators:
Market Value MiMedx|MDXG - Total Company Value
- book capitalization information:
Accounting Value per Share MiMedx|MDXG - Book Capitalization|Market Capitalization to Book Value Ratio mimedx.com|MDXG - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio MiMedx Group, Inc.|MDXG - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio MiMedx Corp|MDXG - Company Aggregate Debts|Debts to Book Value MiMedx|MDXG - Company Long-Term Liabilities|Amount of Current Liabilities MiMedx|Quick Ratio mimedx.com
- earnings and multiples data:
MDXG - Net Profit
Summary company analytics:MiMedx Group, Inc.
Brand item of MiMedx Group, Inc.

A conservative approach requires assessing the long-term financial stability of MiMedx Group, Inc. (MDXG) by analyzing liabilities with a maturity of more than one year. By summing the confirmed debts for each session, the company's long-term debt level demonstrates the cost of servicing liabilities, which is critical for scaling high-margin biomaterial production and minimizing risks during the expansion of regenerative technologies into clinics.

Competitor analysis for MiMedx Group, Inc.

Company Long-Term Debts ascendispharma.com ASND|MDGL - Company Long-Term Debt|Company Long-Term Loans and Borrowings CORT (Corcept Therapeutics Inc.)|Rhythm Pharmaceuticals Inc (RYTM) - Company Long-Term Debt|Company Long-Term Liabilities Akero Corp|MTSR (Metsera Inc) - Company Long-Term Debts|Company Long-Term Debts moonlaketx.com|Company Long-Term Liabilities CRNX (Crinetics)|NAMS (NewAmsterdam Pharma Company) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Soleno SLNO|FOLD - Company Long-Term Liabilities|89bio, Inc. - Company Long-Term Debts|Long-Term Debt agios.com|GPCR (Structure Therapeutics Inc.) - Company Long-Term Liabilities|RZLT: Amount of Long-Term Liabilities|LXRX (Lexicon Pharma) - Company Long-Term Debts|Company Long-Term Debts MBX Corp|Company Long-Term Debts ALT|Company Long-Term Debt AARD (aardvarktherapeutics.com)|Company Long-Term Debt Sagimet Biosciences Inc. SGMT|BioAge Labs (BIOA) - Long-Term Debt|BMEA - Company Long-Term Debt|QNCX: Company Long-Term Debt|GUTS: Company Long-Term Debts|VTVT - Long-Term Debt Volume|Company Long-Term Debt Agape ATP Corp|Pluri Inc (PLUR) - Long-Term Debt Volume|Company Long-Term Debt Synlogic, Inc. (SYBX)|Company Long-Term Liabilities Lipocine Corporation LPCN|Company Long-Term Debt Matinas BioPharma Holdings MTNB|SPRB - Company Long-Term Liabilities|Galecto - Company Long-Term Debts|Long-Term Debt Volume Carmell Corp. CTCX|Lumos Pharma Corp (LUMO) - Company Long-Term Debt|Company Long-Term Liabilities Organovo Corp|RDUS (Radius Recycling, Inc.) - Company Long-Term Debts